Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA
July 07 2021 - 8:00AM
Business Wire
AditxtScoreTM Center to Become Global
Headquarters for Aditxt as a Biotech Innovator Focused on Immune
Health
Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a
mission to improve the health of the immune system, today announced
the opening of its AditxtScore™ Center in Richmond, VA. This
high-capacity, CLIA-validated immune monitoring center will be
scalable to process several million complex immune system reports
per year.
“The opening of the AditxtScore Center is a key step on
AditxtScore’s path to market, serving as a critical enabler to
commercializing a new platform for personalized health,” said Amro
Albanna, Co-founder and Chief Executive Officer of Aditxt. “In
addition to its operational and commercial capabilities, this
facility will also help accelerate new AditxtScore application
development activities to address markets with significant growth
potential.”
Introduced earlier this year in a joint press conference
including Governor Ralph Northam and Richmond Mayor Levar Stoney,
the AditxtScore Center was built to support the growth of the
AditxtScore platform, a pioneering new approach to immune and
health monitoring that provides a personalized profile of the
immune system. By assessing an individual's immune biomarkers,
AditxtScore is designed to measure indications of immune response
to specific disease. AditxtScore applications include the recently
commercialized AditxtScore for COVID-19, developed for use in
detecting antibodies against SARS-CoV-2 antigens.
AditxtScore is offered through authorized channel partners. To
find an AditxtScore Channel Partner near you, please visit
www.aditxtscore.com. AditxtScore is available for use as a
CLIA-validated laboratory developed test (LDT). This test is not
for self-diagnosis and is not cleared nor approved by the FDA.
About Aditxt:
Aditxt is developing technologies specifically focused on
improving the health of the immune system through immune monitoring
and reprogramming. Aditxt’s immune monitoring technology is
designed to provide a personalized comprehensive profile of the
immune system. Aditxt’s immune reprogramming technology is
currently at the pre-clinical stage and is designed to retrain the
immune system to induce tolerance with an objective of addressing
rejection of transplanted organs, autoimmune diseases, and
allergies. For more information, please visit: www.aditxt.com
Forward-Looking Statements
Certain statements in this press release constitute
“forward-looking statements” within the meaning of federal
securities laws. Forward looking statements include statements
regarding the Company’s intentions, beliefs, projections, outlook,
analyses or current expectations concerning, among other things,
the Company’s ongoing and planned product and business development;
the Company’s intellectual property position; the Company’s ability
to develop commercial functions; expectations regarding product
launch and revenue; the Company’s results of operations, cash
needs, spending, financial condition, liquidity, prospects, growth
and strategies; the industry in which the Company operates; and the
trends that may affect the industry or the Company. Forward-looking
statements are not guarantees of future performance and actual
results may differ materially from those indicated by these
forward-looking statements as a result of various important
factors, as well as those risks more fully discussed in the section
titled “Risk Factors” in the Company’s most recent Annual Report on
Form 10-K, as well as discussions of potential risks,
uncertainties, and other important factors in the Company’s other
filings with the Securities and Exchange Commission. All such
statements speak only as of the date made, and the Company
undertakes no obligation to update or revise publicly any
forward-looking statements, whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210707005221/en/
Sunny Uberoi Chief Communications Officer Aditxt
ir@aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Jul 2023 to Jul 2024